( University of California - San Diego ) A team of physicians and scientists from the University of California, San Diego School of Medicine, and elsewhere describe using a combination of broadly available medical tests to produce a much improved predictive picture of the likelihood of impending AD in patients with mild cognitive impairment — an intermediate stage between the expected cognitive …
By measuring ratios of two fatty compounds in blood, doctors are now better able to predict how rapidly somebody with Alzheimer’s disease is likely to lose cognitive function, researchers from Johns Hopkins University School of Medicine reported in the Journal of Alzheimer’s Disease. The authors explain that being able to predict cognitive decline could be useful for treatment targets, as well …
The general perception of Alzheimer’s disease, including the dominant theory about what causes it, needs to shift, according to an editorial co-written by a Penn State College of Medicine faculty member. In “Changing Perspectives on Alzheimer’s Disease: Thinking Outside the Amyloid Box,” Penn State College of Medicine’s Daniel George, said the common belief that scientists will soon conquer the …
If you’re a moderate social drinker, your habits may be helping stave off Alzheimer’s, dementia and cognitive impairment, according to Loyola University researchers.Loyola’s Stritch School of Medicine reviewed studies dating to 1977 that included more than 365,000 participants, a release from the school said. Moderate drinkers were 23 percent less likely to develop cognitive impairment or …
Grape seed contains natural antioxidants called polyphenols that may help ward off Alzheimer’s Disease, according to researchers at the Mount Sinai School of Medicine in New York City who write about their findings in a paper about to be published in the Journal of Alzheimer’s Disease. Previous studies have suggested that the small soluble clusters of A-beta protein, called “oligomers”, found in …
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer’s hits first, researchers at Washington University School of Medicine in St. Louis report.
May 2, 2011 - Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer’s hits first, researchers at Washington University School of Medicine in St. Louis report.
( University of Pennsylvania School of Medicine ) In the largest study of its kind, researchers from a consortium led by the University of Pennsylvania School of Medicine, the University of Miami, and the Boston University School of Medicine, identified four new genes linked to Alzheimer’s disease.
A massive scientific effort has found five new gene variants linked to Alzheimer’s disease. The finding may lead to earlier detection of Alzheimer’s disease as well as to new treatments.
Mothers may be more likely to pass down Alzheimer’s disease to their children than fathers, a finding that may help identify patients earlier, researchers from the University of Kansas School of Medicine said.
MONDAY, Feb. 28 (HealthDay News) — A new study adds more weight to research showing the risk of developing Alzheimer’s disease is greater if your mother, rather than your father, had the disorder.
Tampa, FL (Aug.
A researcher with the Faculty of Medicine & Dentistry at the University of Alberta has discovered that a drug originally intended for diabetes may hold promise in the fight against Alzheimer’s disease.
The launch of the International Genomics of Alzheimer’s Project (IGAP) - a collaboration formed to discover and map the genes that contribute to Alzheimer’s disease - was announced today by a multi-national group of researchers including Drs. Lindsay Farrer and Sudha Seshadri at Boston University School of Medicine (BUSM). The collaborative effort, spanning universities from both sides of the …
Researchers from Boston University School of Medicine are part of an international collaboration, announced today, to discover and map all of the genes linked to Alzheimer’s disease in an effort to improve treatments. The collaboration, which includes groups of scientists…
Both Ben Poore and his caregiver, Vicki Selvaggio, are grateful for Southern Illinois University School of Medicine’s Alzheimer’s disease center in Springfield.
Alzheimer’s disease researcher Mark Smith, CWRU School of Medicine professor, was considered a “renegade researcher” for the way he challenged drug companies’ assumptions and other conventional wisdom on Alzheimer’s. But his opinions were gaining increasing attention, though, particularly after the failure of Eli Lilly’s Alzheimer drug in August. He was 45.
Alzheimer’s disease appears to be caused by the brain’s poor elimination of a plaque component, beta-amyloid protein, rather than simply the accumulation of it, researchers from Washington University School of Medicine, St. Louis revealed in the journal Science. We already knew that beta-amyloid protein accumulation occurs in Alzheimer’s patients; this study reveals something nobody knew - that …
Alzheimer’s cause is the poor clearance of beta-amyloid protein as suggested by US scientists after they have conducted a small study done in the University of Medicine, St. Louis.
A New Jersey neuroscientist deeply involved in Alzheimer’s research said that in just two years, doctors may have the medicine to treat the brain-killing disease.